Effect of 5-Aminolevulinic Acid Photodynamic Therapy on Aspergillus fumigatus Biofilms in Vitro

被引:0
作者
Zhimin Duan
Jianbo Tong
Nana Zheng
Rong Zeng
Yuzhen Liu
Min Li
机构
[1] Nanjing Jiangning Hospital,Department of Dermatology
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,Hospital for Skin Diseases (Institute of Dermatology), Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs
[3] The First Affiliated Hospital of Nanchang University,Department of Dermatology, Institute of Dermatology, Jiangxi Academy of Clinical Medical Sciences
[4] Nanjing Medical University,Center for Global Health, School of Public Health
[5] The First Affiliated Hospital of Yunnan Traditional Chinese Medicine University,Department of Dermatology
来源
Current Microbiology | 2023年 / 80卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Aspergillus fumigatus biofilm development results in enhanced pathogenicity and treatment resistance. Most contemporary antibiotics, however, are unable to eliminate biofilms. In recent years, with the application of new photosensitizers and the development of treatment, ALA-PDT (5-aminolevulinic acid photodynamic treatment) has achieved remarkable curative effect in the treatment of fungal infectious diseases; however, no research has been conducted on ALA-PDT against A. fumigatus. This study investigated the inhibitory effect of ALA-PDT at various 5-aminolevulinic acid concentrations and light doses on A. fumigatus planktonic and biofilms in vitro. We found that ALA-PDT may successfully inhibit the development of A. fumigatus biofilm and disintegrate mature biofilm. After ALA-PDT treatment, the adherence rate and vitality dramatically decreased, and the biofilm’s structure was severely compromised. Our findings show for the first time that ALA-PDT may be used to prevent the formation of A. fumigatus biofilm and disturb the structure of mature biofilm, and that it could be employed as a therapeutic therapy for A. fumigatus superficial infection.
引用
收藏
相关论文
共 124 条
[1]  
Gallais F(2017)Simultaneous primary invasive cutaneous aspergillosis in two preterm twins: case report and review of the literature BMC Infect Dis 17 535-544
[2]  
Denis J(1996)Unusual cause of lethal pulmonary aspergillosis in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 154 541-1601
[3]  
Koobar O(2007)Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients Drugs 67 1567-886
[4]  
Pittet D(2005)Systemic fungal infections caused by Curr Drug Targets 6 875-415
[5]  
Huguenin T(2002) species: epidemiology, infection process and virulence determinants N Engl J Med 347 408-1212
[6]  
Dharan S(2007)Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis J Med Microbiol 56 1205-3035
[7]  
Maschmeyer G(2011)Development of a simple model for studying the effects of antifungal agents on multicellular communities of Antimicrob Agents Chemother 55 3031-1284
[8]  
Haas A(2008)In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different J Antimicrob Chemother 62 1281-4136
[9]  
Cornely OA(2008) and Antimicrob Agents Chemother 52 4130-7688
[10]  
Brakhage AA(2016) species Appl Microbiol Biotechnol 100 7679-73